MedPath

Yonsei University

Yonsei University logo
🇰🇷South Korea
Ownership
Private
Established
1885-01-01
Employees
5K
Market Cap
-
Website
http://www.yonsei.ac.kr

Belotecan and Cisplatin in Treating Patients With Previously Untreated, Extensive-Stage Small Cell Lung Cancer

Phase 2
Completed
Conditions
Lung Cancer
Interventions
First Posted Date
2008-09-18
Last Posted Date
2014-12-02
Lead Sponsor
Yonsei University
Target Recruit Count
42
Registration Number
NCT00754858
Locations
🇰🇷

Yonsei Cancer Center at Yonsei University Medical Center, Seoul, Korea, Republic of

Normative Database of the Retinal Nerve Fiber Layer Thickness Measured by the Cirrus HD OCT in Asians

Conditions
Glaucoma
First Posted Date
2008-09-01
Last Posted Date
2008-09-01
Lead Sponsor
Yonsei University
Target Recruit Count
200
Registration Number
NCT00744705
Locations
🇰🇷

Yongdong Severance Hospital, Yonsei University College of Medicine, Seoul, Korea, Republic of

Discriminating Ability of the Cirrus High Definition (HD) Optical Coherence Tomography (OCT) for Glaucoma

Conditions
Glaucoma
First Posted Date
2008-08-27
Last Posted Date
2008-09-23
Lead Sponsor
Yonsei University
Target Recruit Count
200
Registration Number
NCT00742378
Locations
🇰🇷

Gong Je Seong, Seoul, Korea, Republic of

Retinal Nerve Fiber Layer Thickness Measurement on Parapapillary Atrophy With the Cirrus High-Definition (HD) Optical Coherence Tomography (OCT)

Conditions
Glaucoma
First Posted Date
2008-08-27
Last Posted Date
2008-08-27
Lead Sponsor
Yonsei University
Target Recruit Count
30
Registration Number
NCT00742196
Locations
🇰🇷

Gong Je Seong, Seoul, Korea, Republic of

Corrected Measurement of the Retinal Nerve Fiber Layer Thickness by Optic Disc Configuration With the Cirrus HD OCT

Conditions
Glaucoma
Myopia
First Posted Date
2008-08-26
Last Posted Date
2008-08-26
Lead Sponsor
Yonsei University
Target Recruit Count
50
Registration Number
NCT00741130
Locations
🇰🇷

Gong Je Seong, Seoul, Korea, Republic of

First-Line Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery

First Posted Date
2008-08-18
Last Posted Date
2011-02-24
Lead Sponsor
Yonsei University
Target Recruit Count
117
Registration Number
NCT00736814
Locations
🇰🇷

Yonsei Cancer Center at Yonsei University Medical Center, Seoul, Korea, Republic of

Antibiotic Susceptibility of Conjunctival Bacterial Isolates From Refractive Surgery Patients

Completed
Conditions
Bacterial Keratitis
First Posted Date
2008-06-30
Last Posted Date
2016-11-01
Lead Sponsor
Yonsei University
Target Recruit Count
105
Registration Number
NCT00707005
Locations
🇰🇷

Yonsei University Health System, Seoul, Kyoungkido, Korea, Republic of

Oral Vitamin B12 Administration for Vitamin B12 Deficiency After Total Gastrectomy

Phase 2
Completed
Conditions
Vitamin B12 Deficiency
Interventions
First Posted Date
2008-06-18
Last Posted Date
2012-07-19
Lead Sponsor
Yonsei University
Target Recruit Count
30
Registration Number
NCT00699478
Locations
🇰🇷

Yonsei university college of medicine, Seoul, Korea, Republic of

Cost-Effectiveness Analysis of Rotavirus Vaccination for Children in Korea

Conditions
Gastroenteritis
Rotavirus Vaccines
Cost-Effectiveness
First Posted Date
2008-05-01
Last Posted Date
2009-02-19
Lead Sponsor
Yonsei University
Target Recruit Count
200
Registration Number
NCT00669929
Locations
🇰🇷

Wonju Christian Hospital, Wonju, Kangwon-do, Korea, Republic of

🇰🇷

Youngdong Severance Hospital, Seoul, Korea, Republic of

🇰🇷

Yonsei University Health System Severance Hospital, Seoul, Korea, Republic of

S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery

Phase 2
Conditions
Esophageal Cancer
First Posted Date
2008-04-16
Last Posted Date
2011-12-06
Lead Sponsor
Yonsei University
Target Recruit Count
32
Registration Number
NCT00659113
Locations
🇰🇷

Yonsei Cancer Center at Yonsei University Medical Center, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath